SlideShare a Scribd company logo
1 of 1
Download to read offline
Acknowledgements
Introduction Alamar Blue Viability Assay Results
Conclusion
Investigated the adjuvant properties of several gold nanovaccines in
vitro by measuring IL-12 cytokine production
Angel A. GarcĂŠs1, Emily Reiser1, Rebekah Drezek1,2
1. Department of Bioengineering, 2. Department of Electrical and Computer Engineering, Rice University, Houston, TX.
Future Directions
Cancer immunotherapy involves
training the natural immune system to
recognize and destroy tumors. In our lab,
gold nanoparticle (AuNP) cancer vaccines
(AuNV) successfully elicited an immune
response in vivo(1). However, we want to
determine which AuNV induces the
highest cytokine production, a property of
adjuvants. Higher cytokine production
theoretically corresponds to a stronger
immune response. Our investigation
involved introducing bare AuNPs, AuNP-
PEG, AuNP-PEG-OVA, AuNP-PEG-Trp2,
and AuNP-PEG-GP100 into J774.A
macrophages (Mac) and measured IL-12
cytokine production and cell viability.
Researching induced cytokine production
informs design of future AuNVs.
1: Lin et al. Nanoscale Research Letters 2013, 8:72
Immune Response Overview
Experimental Methods
EDC/Sulfo-NHS
Peptides
COOH
COOH
COOH
COOH
COOH
COOH
COOH
COOH
COOH
COOH
COOH
COOH
COOH
SH
PEG
Figure 2: Overview of AuNV Conjugation
Gold nanoparticles are PEGylated with HS-PEG5000-
COOH. Peptides are added to the carboxylic acid terminus
via the EDC/Sulfo-NHS mechanism.
Figure 4: Overview of the ELISA sandwich assay
A QuantikineÂŽ ELISA Mouse IL-12 p70 immunoassay
kit (sandwich assay) used. Higher intensities of color
change indicate higher cytokine concentrations
Courtesy of: Chakravarthy, Ankur. “ELISA- Enzyme Linked Immunosorbant Assay”
Figure 3: Overview of the Alamar Blue cell viability assay
J774A.1 mouse macrophages introduced to various AuNV
concentrations. Excitation wavelength: 570 nm. Maximum
fluorescence intensity peak wavelength: 586-588 nm.
Image courtesy: Thermo Scientific alamarBlue assay protocol
0
500000
1000000
1500000
2000000
2500000
3000000
3500000
4000000
MaximumFlorescenceIntensity
Maximum florescence intensity of different AuNVs
at varying concentrations
3.1395E-14 g/cell
6.279E-14 g/cell
9.4185E-14 g/cell
Figure 5: Concentration of AuNVs introduced affects cell
viability in vitro
Almost all AuNVs tested had similar maximum florescence
intensity values, indicating a similar viability. A similar
viability to the control indicates that the AuNVs are not
harming the cells.
Figure 6: IL-12 ELISA sandwich assay performed with
various AuNVs
The ELISA assay was performed in duplicate and average
IL-12 concentrations are reported. The higher the
concentration of IL-12 cytokine produced theoretically
indicates a higher immune response.
ELISA Cytokine Assay Results
Peptide Sequences (Charge)
OVA-1: SIINFEKL (neutral)
GP100: KVPRNQDWL (+1)
Trp2: SVYDFFVWL (-1)
This research was funded with the National Institute of Health (NIH)
grant and A.A.G. was funded by the HHMI Rice Sustaining Excellence
in Research (SER) Scholars program. The Drezek lab provided the
facilities and equipment with which to conduct this research. In
addition, A. GarcĂŠs acknowledges E. Reiser for her mentorship and
support throughout this project.
Objective
• To further evaluate the adjuvant
properties of different AuNVs in vitro
and how these properties are affected by
peptide chemistry
Future experiments
• Viability tests of neo-antigens with
longer chain lengths (Kif18B and Tubb3)
• Peptide scrambling- change AA sequence
order
• Measure IL-12 cytokine production in
different cell lines, such as JAWS-II
• Investigate production of other cytokines,
such as TNF-alpha
• Investigate adjuvant properties using
different sized AuNPs
Additional AuNV information
We investigated the effect of different
AuNVs at four specific dosages on the
production of the IL-12 cytokine in
J774A.1 macrophages as well as
demonstrated their non-toxicity. Both
AuNP-PEG-GP100 and AuNP-PEG-OVA
produced the most IL-12, indicating
potential use in future in vivo experiments.
However, this does not discredit other
AuNVs, such as AuNP-PEG-Trp2, from
further investigation because the uptake
mechanism might differ, possibly inducing
production of different cytokines.
Understanding the adjuvant properties of
different AuNVs allows us to improve the
AuNVs with weaker adjuvant properties
and use the AuNVs with the best adjuvant
properties for future studies.
APC
Figure 1: Overview of AuNV immunology
Macrophages produce cytokines to communicate with
CD4+ cells to coordinate an immune response. The
more cytokines produced correlates to a stronger
immune response.
CD4+ recruits CD8+
cytotoxic T-cells
AuNV activates antigen
presenting cells (APC)
AuNV
CD4+
AuNV activates
macrophages
CD8+
APC
Tumor
Mac
Mac activates
CD4+ helper
T-cells
AuNV DLS Results
AuNP-OVA: inconclusive
AuNP-GP100: 94.0 nm
AuNP-Trp2: inconclusive
AuNP-PEG: 68.9 nm
AuNP: 36.2 nm
0
5
10
15
20
25
30
ConcentrationofIL-12cytokine(pg/mL)
IL-12 cytokine production induced by various
AuNVs in vitro
3.1395E-14 g/cell
6.279E-14 g/cell
9.4185E-14 g/cell
1.2558E-13 g/cell

More Related Content

What's hot

Ubiquitination of Activation-Induced Cytidine Deaminase by RNF126 2011
Ubiquitination of Activation-Induced Cytidine Deaminase by RNF126 2011Ubiquitination of Activation-Induced Cytidine Deaminase by RNF126 2011
Ubiquitination of Activation-Induced Cytidine Deaminase by RNF126 2011Chittampalli (Yasha) N. Yashaswini
 
EXPERIMENTAL EVALUATION OF FOOT-AND-MOUTH DISEASE O SKR VACCINE: PROTECTIVE E...
EXPERIMENTAL EVALUATION OF FOOT-AND-MOUTH DISEASE O SKR VACCINE: PROTECTIVE E...EXPERIMENTAL EVALUATION OF FOOT-AND-MOUTH DISEASE O SKR VACCINE: PROTECTIVE E...
EXPERIMENTAL EVALUATION OF FOOT-AND-MOUTH DISEASE O SKR VACCINE: PROTECTIVE E...EuFMD
 
Mekuria's poster
Mekuria's posterMekuria's poster
Mekuria's posterMekuria Zemede
 
Antioxidant Efficiency
Antioxidant EfficiencyAntioxidant Efficiency
Antioxidant Efficiencyaaiou1
 
NEUTRALISING ANTIBODY RESPONSE POOR PREDICTOR OF HETEROLOGOUS PROTECTION
NEUTRALISING ANTIBODY RESPONSE POOR PREDICTOR OF HETEROLOGOUS PROTECTION NEUTRALISING ANTIBODY RESPONSE POOR PREDICTOR OF HETEROLOGOUS PROTECTION
NEUTRALISING ANTIBODY RESPONSE POOR PREDICTOR OF HETEROLOGOUS PROTECTION EuFMD
 
"Bioluminescent Imaging of Histidyl-Transfer RNA Synthetase-Induced Myositis ...
"Bioluminescent Imaging of Histidyl-Transfer RNA Synthetase-Induced Myositis ..."Bioluminescent Imaging of Histidyl-Transfer RNA Synthetase-Induced Myositis ...
"Bioluminescent Imaging of Histidyl-Transfer RNA Synthetase-Induced Myositis ...Nicholas Young
 
Qualitative aspects of the responses related to protection against FMDV chall...
Qualitative aspects of the responses related to protection against FMDV chall...Qualitative aspects of the responses related to protection against FMDV chall...
Qualitative aspects of the responses related to protection against FMDV chall...EuFMD
 
OS20 - FMD serological blocking ELISA based on VHH for post-vaccination monit...
OS20 - FMD serological blocking ELISA based on VHH for post-vaccination monit...OS20 - FMD serological blocking ELISA based on VHH for post-vaccination monit...
OS20 - FMD serological blocking ELISA based on VHH for post-vaccination monit...EuFMD
 
AVIDITY ELISA PROVIDES A GOOD CORRELATE WITH THE VIRUS NEUTRALIZATION TESTS I...
AVIDITY ELISA PROVIDES A GOOD CORRELATE WITH THE VIRUS NEUTRALIZATION TESTS I...AVIDITY ELISA PROVIDES A GOOD CORRELATE WITH THE VIRUS NEUTRALIZATION TESTS I...
AVIDITY ELISA PROVIDES A GOOD CORRELATE WITH THE VIRUS NEUTRALIZATION TESTS I...EuFMD
 
Elisa hi ai quail
Elisa hi ai quailElisa hi ai quail
Elisa hi ai quailOumed Gerjis
 
DEVELOPMENT OF A LIQUID-PHASE BLOCKING ELISA BASED ON FOOT-AND-MOUTH DISEASE ...
DEVELOPMENT OF A LIQUID-PHASE BLOCKING ELISA BASED ON FOOT-AND-MOUTH DISEASE ...DEVELOPMENT OF A LIQUID-PHASE BLOCKING ELISA BASED ON FOOT-AND-MOUTH DISEASE ...
DEVELOPMENT OF A LIQUID-PHASE BLOCKING ELISA BASED ON FOOT-AND-MOUTH DISEASE ...EuFMD
 
04..elisa kits for peyronie disease research
04..elisa kits for peyronie disease research04..elisa kits for peyronie disease research
04..elisa kits for peyronie disease researchElabscience
 
Lack of induced mutagenesis-Seminario BiologĂ­a Molecular-Juan Restrepo Ruiz
Lack of induced mutagenesis-Seminario BiologĂ­a Molecular-Juan Restrepo RuizLack of induced mutagenesis-Seminario BiologĂ­a Molecular-Juan Restrepo Ruiz
Lack of induced mutagenesis-Seminario BiologĂ­a Molecular-Juan Restrepo RuizJuan Restrepo Ruiz
 
ISMB2010_Poster
ISMB2010_PosterISMB2010_Poster
ISMB2010_PosterSophia Banton
 

What's hot (20)

kcarterORIP2013
kcarterORIP2013kcarterORIP2013
kcarterORIP2013
 
Ubiquitination of Activation-Induced Cytidine Deaminase by RNF126 2011
Ubiquitination of Activation-Induced Cytidine Deaminase by RNF126 2011Ubiquitination of Activation-Induced Cytidine Deaminase by RNF126 2011
Ubiquitination of Activation-Induced Cytidine Deaminase by RNF126 2011
 
EXPERIMENTAL EVALUATION OF FOOT-AND-MOUTH DISEASE O SKR VACCINE: PROTECTIVE E...
EXPERIMENTAL EVALUATION OF FOOT-AND-MOUTH DISEASE O SKR VACCINE: PROTECTIVE E...EXPERIMENTAL EVALUATION OF FOOT-AND-MOUTH DISEASE O SKR VACCINE: PROTECTIVE E...
EXPERIMENTAL EVALUATION OF FOOT-AND-MOUTH DISEASE O SKR VACCINE: PROTECTIVE E...
 
Sjogren ppt
Sjogren pptSjogren ppt
Sjogren ppt
 
Mekuria's poster
Mekuria's posterMekuria's poster
Mekuria's poster
 
Chicken_mAbs_Webinar
Chicken_mAbs_WebinarChicken_mAbs_Webinar
Chicken_mAbs_Webinar
 
Antioxidant Efficiency
Antioxidant EfficiencyAntioxidant Efficiency
Antioxidant Efficiency
 
NEUTRALISING ANTIBODY RESPONSE POOR PREDICTOR OF HETEROLOGOUS PROTECTION
NEUTRALISING ANTIBODY RESPONSE POOR PREDICTOR OF HETEROLOGOUS PROTECTION NEUTRALISING ANTIBODY RESPONSE POOR PREDICTOR OF HETEROLOGOUS PROTECTION
NEUTRALISING ANTIBODY RESPONSE POOR PREDICTOR OF HETEROLOGOUS PROTECTION
 
"Bioluminescent Imaging of Histidyl-Transfer RNA Synthetase-Induced Myositis ...
"Bioluminescent Imaging of Histidyl-Transfer RNA Synthetase-Induced Myositis ..."Bioluminescent Imaging of Histidyl-Transfer RNA Synthetase-Induced Myositis ...
"Bioluminescent Imaging of Histidyl-Transfer RNA Synthetase-Induced Myositis ...
 
Penn
PennPenn
Penn
 
Prevalence of Resistant Enzymes and Their Therapeutic Challenges
Prevalence of Resistant Enzymes and Their Therapeutic ChallengesPrevalence of Resistant Enzymes and Their Therapeutic Challenges
Prevalence of Resistant Enzymes and Their Therapeutic Challenges
 
Qualitative aspects of the responses related to protection against FMDV chall...
Qualitative aspects of the responses related to protection against FMDV chall...Qualitative aspects of the responses related to protection against FMDV chall...
Qualitative aspects of the responses related to protection against FMDV chall...
 
OS20 - FMD serological blocking ELISA based on VHH for post-vaccination monit...
OS20 - FMD serological blocking ELISA based on VHH for post-vaccination monit...OS20 - FMD serological blocking ELISA based on VHH for post-vaccination monit...
OS20 - FMD serological blocking ELISA based on VHH for post-vaccination monit...
 
AVIDITY ELISA PROVIDES A GOOD CORRELATE WITH THE VIRUS NEUTRALIZATION TESTS I...
AVIDITY ELISA PROVIDES A GOOD CORRELATE WITH THE VIRUS NEUTRALIZATION TESTS I...AVIDITY ELISA PROVIDES A GOOD CORRELATE WITH THE VIRUS NEUTRALIZATION TESTS I...
AVIDITY ELISA PROVIDES A GOOD CORRELATE WITH THE VIRUS NEUTRALIZATION TESTS I...
 
Elisa hi ai quail
Elisa hi ai quailElisa hi ai quail
Elisa hi ai quail
 
DEVELOPMENT OF A LIQUID-PHASE BLOCKING ELISA BASED ON FOOT-AND-MOUTH DISEASE ...
DEVELOPMENT OF A LIQUID-PHASE BLOCKING ELISA BASED ON FOOT-AND-MOUTH DISEASE ...DEVELOPMENT OF A LIQUID-PHASE BLOCKING ELISA BASED ON FOOT-AND-MOUTH DISEASE ...
DEVELOPMENT OF A LIQUID-PHASE BLOCKING ELISA BASED ON FOOT-AND-MOUTH DISEASE ...
 
Carbapenamase2
Carbapenamase2Carbapenamase2
Carbapenamase2
 
04..elisa kits for peyronie disease research
04..elisa kits for peyronie disease research04..elisa kits for peyronie disease research
04..elisa kits for peyronie disease research
 
Lack of induced mutagenesis-Seminario BiologĂ­a Molecular-Juan Restrepo Ruiz
Lack of induced mutagenesis-Seminario BiologĂ­a Molecular-Juan Restrepo RuizLack of induced mutagenesis-Seminario BiologĂ­a Molecular-Juan Restrepo Ruiz
Lack of induced mutagenesis-Seminario BiologĂ­a Molecular-Juan Restrepo Ruiz
 
ISMB2010_Poster
ISMB2010_PosterISMB2010_Poster
ISMB2010_Poster
 

Similar to Final Summer IBB poster

Presentation of David Rimm in 1st International Antibody Validation Forum 2014
Presentation of David Rimm in 1st International Antibody Validation Forum 2014Presentation of David Rimm in 1st International Antibody Validation Forum 2014
Presentation of David Rimm in 1st International Antibody Validation Forum 2014St John's Laboratory Ltd
 
Sejal Mistry IAB poster
Sejal Mistry IAB posterSejal Mistry IAB poster
Sejal Mistry IAB posterSejal Mistry
 
Seminario biologia molecular universidad pontificia bolivariana
Seminario biologia molecular universidad pontificia bolivarianaSeminario biologia molecular universidad pontificia bolivariana
Seminario biologia molecular universidad pontificia bolivarianasaravelez0513
 
44-150724PST_Peptalk_2013_AlphaLISA_immunoassays
44-150724PST_Peptalk_2013_AlphaLISA_immunoassays44-150724PST_Peptalk_2013_AlphaLISA_immunoassays
44-150724PST_Peptalk_2013_AlphaLISA_immunoassaysMichael A. Lomotan
 
POLYMERASE CHAIN REACTION (PCR) AND ENZYME-LINKED.pptx
POLYMERASE CHAIN REACTION (PCR) AND ENZYME-LINKED.pptxPOLYMERASE CHAIN REACTION (PCR) AND ENZYME-LINKED.pptx
POLYMERASE CHAIN REACTION (PCR) AND ENZYME-LINKED.pptxAreebWaheed
 
Lab diagnosis of Autoimmune Encephalitis
Lab diagnosis of Autoimmune EncephalitisLab diagnosis of Autoimmune Encephalitis
Lab diagnosis of Autoimmune EncephalitisSantosh Dash
 
ria elisa biochem.pdf
ria elisa biochem.pdfria elisa biochem.pdf
ria elisa biochem.pdfRinaDas9
 
Sensitivity assay of polymerase chain reaction for detection of canine adeno ...
Sensitivity assay of polymerase chain reaction for detection of canine adeno ...Sensitivity assay of polymerase chain reaction for detection of canine adeno ...
Sensitivity assay of polymerase chain reaction for detection of canine adeno ...Alexander Decker
 
Poster_Epitope_mapping_of_persisting_EBV_infection_01
Poster_Epitope_mapping_of_persisting_EBV_infection_01Poster_Epitope_mapping_of_persisting_EBV_infection_01
Poster_Epitope_mapping_of_persisting_EBV_infection_01Paul Von Hoegen
 
Darley Source Poster final
Darley Source Poster finalDarley Source Poster final
Darley Source Poster finalJacob Darley
 
ABRCMS_Poster_11_2015
ABRCMS_Poster_11_2015ABRCMS_Poster_11_2015
ABRCMS_Poster_11_2015Jaminah Norman
 
Poster Presentation-FINAL
Poster Presentation-FINALPoster Presentation-FINAL
Poster Presentation-FINALKevin Knight
 
Vector delivery
Vector deliveryVector delivery
Vector deliveryzwiegers
 

Similar to Final Summer IBB poster (20)

Presentation of David Rimm in 1st International Antibody Validation Forum 2014
Presentation of David Rimm in 1st International Antibody Validation Forum 2014Presentation of David Rimm in 1st International Antibody Validation Forum 2014
Presentation of David Rimm in 1st International Antibody Validation Forum 2014
 
Sejal Mistry IAB poster
Sejal Mistry IAB posterSejal Mistry IAB poster
Sejal Mistry IAB poster
 
Seminario biologia molecular universidad pontificia bolivariana
Seminario biologia molecular universidad pontificia bolivarianaSeminario biologia molecular universidad pontificia bolivariana
Seminario biologia molecular universidad pontificia bolivariana
 
ICAD2008#2Final
ICAD2008#2FinalICAD2008#2Final
ICAD2008#2Final
 
44-150724PST_Peptalk_2013_AlphaLISA_immunoassays
44-150724PST_Peptalk_2013_AlphaLISA_immunoassays44-150724PST_Peptalk_2013_AlphaLISA_immunoassays
44-150724PST_Peptalk_2013_AlphaLISA_immunoassays
 
POLYMERASE CHAIN REACTION (PCR) AND ENZYME-LINKED.pptx
POLYMERASE CHAIN REACTION (PCR) AND ENZYME-LINKED.pptxPOLYMERASE CHAIN REACTION (PCR) AND ENZYME-LINKED.pptx
POLYMERASE CHAIN REACTION (PCR) AND ENZYME-LINKED.pptx
 
GCURS Presentation
GCURS PresentationGCURS Presentation
GCURS Presentation
 
Lab diagnosis of Autoimmune Encephalitis
Lab diagnosis of Autoimmune EncephalitisLab diagnosis of Autoimmune Encephalitis
Lab diagnosis of Autoimmune Encephalitis
 
ria elisa biochem.pdf
ria elisa biochem.pdfria elisa biochem.pdf
ria elisa biochem.pdf
 
2017 BDSRA Berg CLN3
2017 BDSRA Berg CLN32017 BDSRA Berg CLN3
2017 BDSRA Berg CLN3
 
rprotein
rproteinrprotein
rprotein
 
Sensitivity assay of polymerase chain reaction for detection of canine adeno ...
Sensitivity assay of polymerase chain reaction for detection of canine adeno ...Sensitivity assay of polymerase chain reaction for detection of canine adeno ...
Sensitivity assay of polymerase chain reaction for detection of canine adeno ...
 
Poster_Epitope_mapping_of_persisting_EBV_infection_01
Poster_Epitope_mapping_of_persisting_EBV_infection_01Poster_Epitope_mapping_of_persisting_EBV_infection_01
Poster_Epitope_mapping_of_persisting_EBV_infection_01
 
ANA.pptx
ANA.pptxANA.pptx
ANA.pptx
 
PhD_presentation_glenting
PhD_presentation_glentingPhD_presentation_glenting
PhD_presentation_glenting
 
Darley Source Poster final
Darley Source Poster finalDarley Source Poster final
Darley Source Poster final
 
ABRCMS_Poster_11_2015
ABRCMS_Poster_11_2015ABRCMS_Poster_11_2015
ABRCMS_Poster_11_2015
 
Serological test for fungi
Serological test for  fungiSerological test for  fungi
Serological test for fungi
 
Poster Presentation-FINAL
Poster Presentation-FINALPoster Presentation-FINAL
Poster Presentation-FINAL
 
Vector delivery
Vector deliveryVector delivery
Vector delivery
 

Final Summer IBB poster

  • 1. Acknowledgements Introduction Alamar Blue Viability Assay Results Conclusion Investigated the adjuvant properties of several gold nanovaccines in vitro by measuring IL-12 cytokine production Angel A. GarcĂŠs1, Emily Reiser1, Rebekah Drezek1,2 1. Department of Bioengineering, 2. Department of Electrical and Computer Engineering, Rice University, Houston, TX. Future Directions Cancer immunotherapy involves training the natural immune system to recognize and destroy tumors. In our lab, gold nanoparticle (AuNP) cancer vaccines (AuNV) successfully elicited an immune response in vivo(1). However, we want to determine which AuNV induces the highest cytokine production, a property of adjuvants. Higher cytokine production theoretically corresponds to a stronger immune response. Our investigation involved introducing bare AuNPs, AuNP- PEG, AuNP-PEG-OVA, AuNP-PEG-Trp2, and AuNP-PEG-GP100 into J774.A macrophages (Mac) and measured IL-12 cytokine production and cell viability. Researching induced cytokine production informs design of future AuNVs. 1: Lin et al. Nanoscale Research Letters 2013, 8:72 Immune Response Overview Experimental Methods EDC/Sulfo-NHS Peptides COOH COOH COOH COOH COOH COOH COOH COOH COOH COOH COOH COOH COOH SH PEG Figure 2: Overview of AuNV Conjugation Gold nanoparticles are PEGylated with HS-PEG5000- COOH. Peptides are added to the carboxylic acid terminus via the EDC/Sulfo-NHS mechanism. Figure 4: Overview of the ELISA sandwich assay A QuantikineÂŽ ELISA Mouse IL-12 p70 immunoassay kit (sandwich assay) used. Higher intensities of color change indicate higher cytokine concentrations Courtesy of: Chakravarthy, Ankur. “ELISA- Enzyme Linked Immunosorbant Assay” Figure 3: Overview of the Alamar Blue cell viability assay J774A.1 mouse macrophages introduced to various AuNV concentrations. Excitation wavelength: 570 nm. Maximum fluorescence intensity peak wavelength: 586-588 nm. Image courtesy: Thermo Scientific alamarBlue assay protocol 0 500000 1000000 1500000 2000000 2500000 3000000 3500000 4000000 MaximumFlorescenceIntensity Maximum florescence intensity of different AuNVs at varying concentrations 3.1395E-14 g/cell 6.279E-14 g/cell 9.4185E-14 g/cell Figure 5: Concentration of AuNVs introduced affects cell viability in vitro Almost all AuNVs tested had similar maximum florescence intensity values, indicating a similar viability. A similar viability to the control indicates that the AuNVs are not harming the cells. Figure 6: IL-12 ELISA sandwich assay performed with various AuNVs The ELISA assay was performed in duplicate and average IL-12 concentrations are reported. The higher the concentration of IL-12 cytokine produced theoretically indicates a higher immune response. ELISA Cytokine Assay Results Peptide Sequences (Charge) OVA-1: SIINFEKL (neutral) GP100: KVPRNQDWL (+1) Trp2: SVYDFFVWL (-1) This research was funded with the National Institute of Health (NIH) grant and A.A.G. was funded by the HHMI Rice Sustaining Excellence in Research (SER) Scholars program. The Drezek lab provided the facilities and equipment with which to conduct this research. In addition, A. GarcĂŠs acknowledges E. Reiser for her mentorship and support throughout this project. Objective • To further evaluate the adjuvant properties of different AuNVs in vitro and how these properties are affected by peptide chemistry Future experiments • Viability tests of neo-antigens with longer chain lengths (Kif18B and Tubb3) • Peptide scrambling- change AA sequence order • Measure IL-12 cytokine production in different cell lines, such as JAWS-II • Investigate production of other cytokines, such as TNF-alpha • Investigate adjuvant properties using different sized AuNPs Additional AuNV information We investigated the effect of different AuNVs at four specific dosages on the production of the IL-12 cytokine in J774A.1 macrophages as well as demonstrated their non-toxicity. Both AuNP-PEG-GP100 and AuNP-PEG-OVA produced the most IL-12, indicating potential use in future in vivo experiments. However, this does not discredit other AuNVs, such as AuNP-PEG-Trp2, from further investigation because the uptake mechanism might differ, possibly inducing production of different cytokines. Understanding the adjuvant properties of different AuNVs allows us to improve the AuNVs with weaker adjuvant properties and use the AuNVs with the best adjuvant properties for future studies. APC Figure 1: Overview of AuNV immunology Macrophages produce cytokines to communicate with CD4+ cells to coordinate an immune response. The more cytokines produced correlates to a stronger immune response. CD4+ recruits CD8+ cytotoxic T-cells AuNV activates antigen presenting cells (APC) AuNV CD4+ AuNV activates macrophages CD8+ APC Tumor Mac Mac activates CD4+ helper T-cells AuNV DLS Results AuNP-OVA: inconclusive AuNP-GP100: 94.0 nm AuNP-Trp2: inconclusive AuNP-PEG: 68.9 nm AuNP: 36.2 nm 0 5 10 15 20 25 30 ConcentrationofIL-12cytokine(pg/mL) IL-12 cytokine production induced by various AuNVs in vitro 3.1395E-14 g/cell 6.279E-14 g/cell 9.4185E-14 g/cell 1.2558E-13 g/cell